Skip to main content

Table 6 Different HPV subtype infection rates among NILM, ASC, LSIL, and HSIL, respectively

From: Characteristics of women infected with human papillomavirus in a tertiary hospital in Beijing China, 2014–2018

HPV subtypeNILM (%)
N = 19,493
ASC (%)
N = 858
LSIL (%)
N = 561
HSIL (%)
N = 327
HPV16591 (3.03)130 (15.15)73 (13.01)148 (45.26)
HPV18234 (1.20)46 (5.36)16 (2.85)16 (4.89)
HPV31196 (1.01)33 (3.85)19 (3.39)16 (4.89)
HPV33103 (0.53)26 (3.03)14 (2.50)12 (3.67)
HPV35151 (0.77)26 (3.03)17 (3.03)11 (3.36)
HPV39368 (1.89)68 (7.93)41 (7.31)13 (3.98)
HPV4562 (0.32)16 (1.86)5 (0.89)3 (0.92)
HPV51296 (1.52)79 (9.21)76 (13.54)14 (4.28)
HPV52764 (3.92)131 (15.27)59 (10.52)32 (9.79)
HPV56272 (1.40)57 (6.64)98 (17.47)8 (2.45)
HPV58662 (3.40)132 (15.38)58 (10.34)57 (17.43)
HPV59253 (1.30)39 (4.55)18 (3.21)6 (1.83)
HPV68180 (0.92)46 (5.36)27 (4.81)5 (1.53)
  1. HPV human papillomavirus, NILM negative for intraepithelial lesions or malignancy, ASC atypical squamous cells, LSIL low grade squamous intraepithelial lesion, HSIL high grade squamous intraepithelial lesion